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ABSTRACT 
 In this study, 150 patients were recruited out of which 63(42%) were male while 87(58%) were female subjects. Patients 
with type 1 diabetes were 2(1.3%), those with type 2 were 142(94.7%) while those with GDM were 4(4%). Only one sample 
from type 2 was positive by virus isolation and identified to be Echovirus 1 and 21 by microneutralization tests as 
described in WHO polio laboratory manual, 2004. It has been demonstrated that enterovirus infections were significantly 
more common in recently diagnosed diabetic patients, compared to control subjects. The question if enterovirus could 
cause beta cell damage and diabetes mellitus has become more and more relevant when recent studies have provided new 
evidence supporting this scenario especially in type 1 diabetes. This is an important issue since it opens the possibility to 
develop new, preventive and therapeutic strategies to fight the disease. The purpose of this study is to investigate if 
enterovirus can be isolated from the stool samples of diabetic patients as a study. 
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INTRODUCTION  
Diabetes mellitus or diabetes is a lifelong chronic 
disease in which there is high level of sugar in the 
blood which results in symptoms such as blurry 
vision, excess thirst, fatigue, frequent urination, 
hunger and weight loss (1). There are three major 
types of diabetes mellitus: Type 1 diabetes mellitus 
can occur at any age but is most frequently 
diagnosed in children-teen or young adults. In this 
disease the body makes little or no insulin. Type 2 
diabetes mellitus which makes up most diabetes 
cases. It most often occurs in adults (2). It results 
from insulin resistance; a condition in which cells 
fail to utilize insulin properly. Gestational 
diabetes: when pregnant women who have never 
had diabetes before have a high blood glucose 
level during pregnancy.  
Globally, as of 2010, an estimated 285 million 
people had diabetes, with type 2 making up about 
90% of the cases (3). Its incidence is increasing 
rapidly, and by 2030, this number is estimated to 
almost double (4). Diabetes mellitus occurs 
throughout the world, but is more common 
(especially type 2) in the more developed 
countries. The greatest increase in prevalence is, 
however, expected to occur in Asia and Africa, 
where most patients will probably be found by  
 
2030. The increase in incidence in developing 
countries follows the trend of urbanization and 
lifestyle changes, perhaps most importantly a 
"Western-style" diet. This has suggested an 
environmental (i.e., dietary) effect, but there is 
little understanding of the mechanism(s) at 
present, though there is much speculation, some of 
it most compellingly presented (4).  
The infection with enteroviruses seems to be 
linked to the induction of islet-cell autoantibodies 
as well as to the expression of interferon-ά. Both of 
these events are connected with islet-cell 
destruction (5). It has become increasingly 
important to establish the nature of the infecting 
virus in the early stages of diabetes and seems a 
number of viruses of the coxsackie or echovirus 
type are involved, although the nature of the 
nucleotide sequences responsible for 
diabetogenicity remains elusive. Viruses have long 
been considered a major environmental factor in 
the aetiology of type 1 diabetes mellitus and recent 
work has greatly confirmed this role and now 
evident that enteroviral infections accompany the 
onset of diabetes in young people. It is only 
recently that clearer role of this virus in the 
aetiology of diabetes began to emerge despite 





mellitus has no doubt been on the increase for the 
past ten years in Nigeria. The national prevalence 
puts it at about 2.2% and this continues to be on 
the increase (6). Coxsackie B viruses are known to 
cause pancreatitis and diabetes in mice. There is 
some evidence that coxsackie B viruses, 
particularly B4, may play a role in the 
pathogenesis of juvenile onset IDDM. Post 
mortem studies on patients with diabetic 
ketoacidosis and seroepidemiological data have 
implicated coxsackie B viruses. 30% of children 
with IDDM have IgM antibodies to coxsackie B 
viruses compared to 5 - 8% for matched controls. It 
is probable that other cofactors are required. 
The family under this genus include poliovirus, 
coxsackievirus, entero cytopathic human orphan 
(ECHO) virus and enterovirus. Some clinical 
syndromes associated with enteroviruses include 
paralytic diseases, meningo-encephalitis, 
diabetes/ pancreatitis, carditis, neonatal disease, 
etc. (7-9). Enteroviruses are spread via the faecal-
oral route.The primary replication of enteroviruses 
happens in the intestinal cells (10). Didier Hober 
(2010) in his experiment shows that CV-B and 
other enterovirus serotypes can infect and 
replicate in beta cells in- vitro. This infection and 
re-infection can initiate and accelerate beta cell 
impairment through the activation of anti-
enteroviral T- lymphocytes.The detection of 
enterovirus in various tissues, blood, gut, and 
pancreas of patients with type 1 diabetes mellitus 
suggests an association between the virus and the 
disease. (12). Type 1 diabetes usually starts in 
young people and results from the destruction of 
insulin producing beta cells in the pancreas. An 
extension of the study showed that 40% of adults 
with type 2 diabetes have had infection in insulin 
producing cells i.e. beta cells (13).These beta cells 
are not destroyed in these diseases but their ability 
to make insulin is compromised. The way this 
enterovirus might contribute to the development 
of type 2 diabetes has not been established, but it’s 
known from laboratory studies that an enteroviral 
infection of beta cells reduces their ability to 
produce insulin (14). 
 Enterovirus and type 1 diabetes  
Type 1 diabetes usually starts in young people and 
results from the destruction of the insulin-
producing beta cells in the pancreas. Enteroviruses 
infect the pancreas of patients; in addition, the 
infection of other tissues in human beings has 
been reported as well. The detection of 
enteroviruses in various tissues, blood, gut, and 
pancreas of patients with T1D suggests an 
association between these viruses and the disease 
(12).CV-B and other enterovirus serotypes can 
infect human islets and can replicate in β-cells in 
vitro, which stimulates the production of 
cytokines (soluble mediators of the 
“communication” between immune cells) and 
membrane proteins at the surface of β-cells that 
are able to intervene in pathogenic processes. CV-
B4 inoculated to mice resulted in diabetes with 
viral replication in β-cells. CV-B replicated in 
human β-cells in vitro. An expression of IFN-α by 
β-cells was observed (15). IFN-α can play a 
pathogenic role through induction of class I HLA 
molecules and ICAM-1 at the surface of β-cells, 
which is a characteristic of β-cells of patients with 
T1D. It is interesting to note that transgenic mice 
whose β-cells express IFN-α develop diabetes as a 
result of insulitis and β-cell destruction, due to 
activation of autoimmune effector cells against 
islets (16). In addition, maternal enterovirus 
infections during pregnancy have been linked to 
an increased risk of type 1 diabetes in the offspring 
(17). 
Enterovirus and type 2 diabetes 
An extension of the study to adults with type 2 
diabetes showed that a large proportion of the 
same age group. Unlike type 1 diabetes, type 2 
diabetes usually starts in adults and is associated 
with obesity. The beta cells are not destroyed in 
this disease but their ability to make insulin is 
compromised. The way that enteroviruses might 
contribute to the development of type 2 diabetes 
has not been established but it is known from 
laboratory studies that an enteroviral infection of 
beta cells reduces their ability to release insulin. It 
is possible that in people who are obese (where 
there is a greatly increased demand for insulin 
secretion) a reduction of beta cell function, 
secondary to enteroviral infection, may be 
sufficient to trigger type 2 diabetes - although 
more research is required to confirm this.(18). 
Another recent study to be published in 
www.phgfoundation.org/news/4515/ proposed 
link between T1D and enterovirus infection which 
reports the detection of enteroviruses in pancreatic 
tissue from about 60% of 72 paediatric patients 
with T1D, but very few of the samples of tissue 
from 50 children without the disease (20). This 
research also found that 40% of adults with type 2 
diabetes showed signs of enteroviral infection of 
their pancreatic beta cells, compared with only 13 
percent of non-diabetic (control) adults of the 
same age. The authors propose that vaccination 
against enteroviral infection in childhood could 
reduce the incidence of both common forms of 
diabetes.  
 MATERIALS AND METHODS 
Study area:  
Stool samples were collected from adults who 
visited University of Maiduguri Teaching Hospital 
(UMTH), Maiduguri, Nigeria for medical attention 





health institution located in Borno State, Nigeria 
and serves as a referral health centre for six states 
(Adamawa, Bauchi, Borno, Gombe, Taraba and 
Yobe,) in northeastern Nigeria and neighboring 
African countries (Chad to the northeast, Niger to 
the north and Cameroon to the east). Based on the 
2006 provisional census figures, Borno State has a 
population of 4,151,193 and a population density 
of approximately 60 inhabitants per square 
kilometer.The state has an area of 61,435sq.km (the 
largest state in Nigeria in terms of land mass).(21). 
Study population:  
The Ethical Committee of University of Maiduguri 
Teaching Hospital, Maiduguri gave approval to 
the study protocol. Only patients with confirmed 
diabetes were recruited for the study. After 
obtaining informed consent from those subjects, 
willing participants were enrolled consecutively in 
the study. Demographic data were collected. 
History of the subjects studied:  
The record of the subjects tested was not available 
but information in this regard was obtained was 
verbal. However,  
Sample collection:  
A total of 150 stool samples were collected from 
the subjects studied between January and 
February 2012. Clean universal containers are 
given to each patient to be returned the next day 
with fresh fecal sample (about 2g or the size of an 
adult thumb). The stool samples were properly 
labelled and transported to the World Health 
Organization National Polio Laboratory, 
Maiduguri for storage and analysis. The entire 
stools were stored at -20°C until tested. 
Virus Isolation and Identification / 
Microneutralization tests for Non Polio 
enteroviruses. 
The methods adopted for virus isolation and 
microneutrlization for identification of isolates 
were described in WHO Polio Laboratory Manual 
(2004) and the supplemental manual of (2006) for 
the New Algorithm Technique currently used for 
poliovirus isolation. Feacal samples were pre-
treated with chloroform and phosphate buffered 
saline and centrifuged at 3000 rpm for 30 minutes, 
200ul of the supernatant was inoculated onto 
healthy monolayer of L20B and 
Rhabdomyosarcoma (RD) cell lines (Source: 
Centre for Disease Control and Prevention, 
Atlanta. USA) in maintainance medium (Eagle’s 
MEM Supplemented with 2% Fetal Calf Serum 
(FCS). The cells were seeded 48 hours prior to 
inoculation with growth medium (Eagle’s MEM 
supplemented with 10% FCS). The inoculated 
monolayers were incubated at 360C and observed 
daily for the characteristic enterovirus cytopathic 
effects (CPE) of rounded refractile cells and 
detaching from the surface of the tube. The tubes 
with CPE up to 75% and above were harvested 
and kept at -200C to be passaged to a fresh 
monolayer of the second cell line. While those 
negative after 5 days of incubation at 360C were re-
passaged on the same cell line. Tubes showing no 
CPE after the second five days were considered as 
negative. With the New Algorithm Technique, 
Positive isolates usually end in RD cell line 
because virus titre seems higher in RD than L20B. 
Positive samples on RD cells were passaged onto 
L20B, the selective cell line for poliovirus. 
Identication of isolates on RD cells was carried out 
by microneutralization technique using antisera 
raised in horse against coxsackie and echoviruses 
prepared by the National Institute of Public 
Health and Enviroment (RIVM), Netherlands. 
 
RESULTS 
Students SPSS version 16 was used for the 
computation and the results obtained are below: 
 
TABLE 1.  NUMBER OF DIABETES TYPES WITH PERCENTAGES N=150. 
Types of Diabetes     Number tested    Percentage (%)  
Type 1      2     1.3 
Type 2      142     94.7 
Gestational diabetes (GDM)    6     4 
Total      150     100 
 
Table 1 presents the number and percentages of 
diabetic patients with the 3 types of diabetes. It is 
shown that type 2 is the most predominant with 
142(94.7%), followed by gestational diabetes 
(GDM) in 6(4%) pregnant women and type 1 with 
lowest with 2(1.3%) patients. 
Table 2 represents the age range of the 150 diabetic 





samples, 2(1.3%) were less than 20years, 6(4.0%) 
were within the age group of 21-29, 17(11.3%) 
were within 30-39, 49(32.9%) within 40-49, 
50(33.3%) within 50-59, while 26(17.3%) were 
within 60 and above. It can be inferred that most 
diabetic onset starts the age of fourties. In addition 
the highest number of patients falls in the fifties as 
a result of ageing factors. 
TABLE 2.  AGE RANGE DISTRIBUTION OF DIABETIC PATIENTS N=150. 
Age groups (yrs)               Number (150)   Percentage (%) 
≤ 20 2 1.3 
21 – 29 6 4.0 
30 – 39 17 11.3 
40 – 49 49 32.7 
50 – 59 50 33.3 
60 – 69 24 16 
≥ 70 2 1.3 
Total   150 100 
TABLE 3: DISTRIBUTION OF DIABETIC PATIENTS BY DURATION / ONSET 
Duration / Onset (yrs)  Number (150)   Percentage (%) 
1 - 5 98 65.3 
6 – 10 32 21.3 
11 – 15 11 7.3 
16 – 20 4 2.7 
21 – 25 3 2.0 
26 – 30 2 1.3 
Total  150 100  
 
Table 3 shows the distribution of patients with the 
duration of onset of diabetes in years. Out of 150 
patients whose samples were used, 98(65.3%) have 
had diabetes for less than or equal to 5years, 
32(21.3%) for about 6-10years, 11(7.3%) for about 
11-15years, 4(2.7%) for about 16-20years, while 
2(1.2%) have had it for about 26-30years.The 
highest figure obtained with onset of 1-5years 
might be due to increased publicity and awareness 
of the people. This reflects increase in number of 
diabetic patients with decreased year(s) of onset 
that seeks medical attention.  
DISCUSSION Enteroviruses have long been 
considered a major environmental factor in the 
aetiology of diabetes mellitus (5). These viruses 
have been detected from diabetic patients more 
often than from control subjects and they can 
infect beta cells in cell culture and induce diabetes 
in animal models (23). A research conducted by 
Salminen (2004) in Finland on children between 6-
18 years, revealed that enterovirus can be isolated 
in stool samples.   
In this work, out of 150 samples collected 63(42%) 
were male while 87(58%) were female subjects 
also, subjects with type 1 were 2(1.3%), type 2 
were 142(94.7%) and GDM were 6(4%), this is 
owing to the fact that type 2 is the most common 
type which is due primarily to lifestyle 
modification, genetics and viruses (25). The only 
positive sample was from a male subject with type 
2 diabetes and fell within the age bracket of 50-59 
with duration of within 11-15 years. There is no 
related literature to justify why it was male and 





The Echovirus 1 and 21 that was isolated from the 
positive case might not be responsible for the 
aetiology of Type 2 diabetes as this may not be 
unconnected with the poor hygiene standards 
commonly observed in most communities as 
previously reported (26). In addition this serotypes 
were not among the ones isolated in aetiology of 
acute flaccid paralysis in northern Nigeria of which 
this study area was inclusive (27) meaning that 
further researches need to establish echovirus in 
aetiology of Type 2 diabetes. However, the fact that 
no absolute association has been identified with 
certain viral strains or even viral geniuses or 
families indicates that, if Type 1 diabetes is indeed 
caused by viruses, multiple infectious strains may 
result in the same disease phenotype (28). In 
conjecture, there is need for further researches at 
molecular level to establish this fact or probably the 
unbiased metagenomics techniques. 
 
The Gestational Diabetes Mellitus (GDM) came into 
consideration as maternal enterovirus infection is a 
risk factor for Type 1 diabetes in the exposed 
offspring (17). This emphasizes the fact that 
pregnant women needs to be screened for 
enterovirus infection to carry out preventable 
measures before delivery of the offspring. In 
addition, there is need to implement health 
education in Antenatal clinics in this regards. There 
is no documented evidence regarding the 
association of enterovirus in the aetiology of Type 2 
diabetes which form 94.7% of the patients tested, 
and no virus isolation was made. Considering the 
duration of the onset of the infection, 0-5 range has 
the highest with 68.8% which might not be 
unconnected with the increased awareness of the 
people even at the grass root level. However, more 
publicity is still required with the provision of basic 
care at the Primary Health Care facility which is 
supposed to be made available at the closest reach 
of every Nigeria. However, the timing cannot be 
underplayed as a component determining virally 
mediated modulation of autoimmunity appears to 
be the time at which infection occurs during the pre-
diabetic phase e.g. type 1 diabetes is enhanced in 8 
week old NOD mice infected with Coxsackie B4, 
infection of younger mice has no effect on disease 
outcome which suggests that the status of 
autoimmune progression is a crucial determinant in 
the diabetogenic potency of the virus (29). The 
highest prevalence was within 50-59 years with 
33.3%, followed by 40-49 years with 32.7% which of 
course might be due to ageing factor. 
 
In conclusion, these patients samples based on 
retrospective study showed that they are diabetic 
patients. Only 1 (0.6%) of the patient with type 2 
diabetes stool sample were positive while 99.3% 
were negative. Based on this result it cannot be 
concluded that enteroviruses do not cause 
diabetes mellitus, various factors has to be 
considered such as; Type of diabetes, patients 
residence / environment, timing of infection and 
subjects hygiene standards enteroviral destruction 
of β-cells of the pancreas occurs years before 
clinical symptoms of diabetes appears. If samples 
were collected at onset of clinical symptoms then 
most of this virus could be isolated. In addition, 
there is need to establish the role of echovirus in 
the aetiology of diabetes by advanced unbiased 
metageomics technique, which will give a clearer 
information and data. 
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